187 related articles for article (PubMed ID: 28454591)
21. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
[TBL] [Abstract][Full Text] [Related]
22. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
23. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
Meric-Bernstam F; Brusco L; Daniels M; Wathoo C; Bailey AM; Strong L; Shaw K; Lu K; Qi Y; Zhao H; Lara-Guerra H; Litton J; Arun B; Eterovic AK; Aytac U; Routbort M; Subbiah V; Janku F; Davies MA; Kopetz S; Mendelsohn J; Mills GB; Chen K
Ann Oncol; 2016 May; 27(5):795-800. PubMed ID: 26787237
[TBL] [Abstract][Full Text] [Related]
24. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
25. Germline genetic variability in pancreatic cancer risk and prognosis.
Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
[TBL] [Abstract][Full Text] [Related]
26. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
[TBL] [Abstract][Full Text] [Related]
27. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
28. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
[TBL] [Abstract][Full Text] [Related]
29. Understanding pancreatic cancer genomes.
Cowley MJ; Chang DK; Pajic M; Johns AL; Waddell N; Grimmond SM; Biankin AV
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):549-56. PubMed ID: 23660961
[TBL] [Abstract][Full Text] [Related]
30. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
[TBL] [Abstract][Full Text] [Related]
31. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
[TBL] [Abstract][Full Text] [Related]
32. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Truong H; Breen K; Nandakumar S; Sjoberg DD; Kemel Y; Mehta N; Lenis AT; Reisz PA; Carruthers J; Benfante N; Joseph V; Khurram A; Gopalan A; Fine SW; Reuter VE; Vickers AJ; Birsoy O; Liu Y; Walsh M; Latham A; Mandelker D; Stadler ZK; Pietzak E; Ehdaie B; Touijer KA; Laudone VP; Slovin SF; Autio KA; Danila DC; Rathkopf DE; Eastham JA; Chen Y; Morris MJ; Offit K; Solit DB; Scher HI; Abida W; Robson ME; Carlo MI
Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772
[TBL] [Abstract][Full Text] [Related]
33. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting.
Lee B; Tran B; Hsu AL; Taylor GR; Fox SB; Fellowes A; Marquis R; Mooi J; Desai J; Doig K; Ekert P; Gaff C; Herath D; Hamilton A; James P; Roberts A; Snyder R; Waring P; McArthur G
Intern Med J; 2018 Jul; 48(7):786-794. PubMed ID: 29607586
[TBL] [Abstract][Full Text] [Related]
34. Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.
Slavin T; Neuhausen SL; Rybak C; Solomon I; Nehoray B; Blazer K; Niell-Swiller M; Adamson AW; Yuan YC; Yang K; Sand S; Castillo D; Herzog J; Wu X; Tao S; Chavez T; Woo Y; Chao J; Mora P; Horcasitas D; Weitzel J
Cancer Genet; 2017 Oct; 216-217():111-119. PubMed ID: 29025585
[TBL] [Abstract][Full Text] [Related]
35. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract][Full Text] [Related]
38. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes.
Mizukami K; Iwasaki Y; Kawakami E; Hirata M; Kamatani Y; Matsuda K; Endo M; Sugano K; Yoshida T; Murakami Y; Nakagawa H; Spurdle AB; Momozawa Y
EBioMedicine; 2020 Oct; 60():103033. PubMed ID: 32980694
[TBL] [Abstract][Full Text] [Related]
39. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
[TBL] [Abstract][Full Text] [Related]
40. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
